Roche PS (ROP.SW)

Real-time intraday values

Market Overview

From:

To:

ROP.SW Intraday

No data available

SymbolROP.SW

IPO DateApr 3, 1995

CEODr. Severin Schwan Ph.D.

Full Time EmployeesN/A

SectorHealthcare

IndustryDrug Manufacturers - General

CountrySwitzerland

ExchangeSwiss

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.

Performance

Period	Return %	Value Change
1 Day	-0.31%	-1.20 US$
5 Days	+3.09%	+11.70 US$
1 Month	+7.63%	+27.70 US$
6 Months	+21.40%	+68.90 US$

Analyzing Market with AI

Evaluating the last 30 days of history and fundamental metrics of ROP.SW...

Key Statistics

Market Cap

311.46B

P/E Ratio

25.50

Div Yield

2.51%

52W High

$395.00

52W Low

$258.20

Analyst Consensus

ConsensusBuy

Bullish1152.4%

Neutral942.9%

Bearish14.8%

52W Analyst Price Targets

Min Target
$250.00

Max Target
$440.00

Current$390.90

Avg Target$385.86

Community Thoughts

Share your analysis and sentiment on ROP.SW

Join the community to share your analysis